Stampa questa pagina

Ippolito Antonio Massimo

Informazioni aggiuntive

  • Cognome Nome: Ippolito Antonio Massimo
  • Dipartimento: Scienze Mediche
  • Reparto: Gastroenterologia e Endoscopia Digestiva
  • Qualifica: Dirigente Medico
  • Telefono Reparto: 0882410785
  • Pubblicazioni Scientifiche: Elenco Pubblicazioni Scientifiche

    Totale pubblicazioni a partire dal 2011: 31


    2019; ():

    High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

    Pellicelli A, Messina V, Giannelli V, Distefano M, Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri S, Dell'Isola S, Marignani M, Scifo G, Iovinella V, Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito AM, B


    2018; 6(2): 225-237

    Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.

    Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A, ITAL-C consortium.


    2018; 53(): 79-84

    Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas.

    Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M


    2017; ():

    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

    Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F


    2017; ():

    Hepatitis C Virus Clearance in Older Adults.

    Ippolito AM, Iacobellis A, Milella M, Conti F, Messina V, Valvano MR, Niro GA, Morisco F, Barone M, Termite AP, Brancaccio G, Andriulli A


    2017; 262(): 179-184

    Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.

    Angelico F, Corradini SG, Pastori D, Fargion S, Fracanzani AL, Angelico M, Bolondi L, Tozzi G, Pujatti PL, Labbadia G, Corazza GR, Averna M, Perticone F, Croce G, Persico M, Bucci T, Baratta F, Polimeni L, Del Ben M, Violi F, LAL-Cirrhosis Collaborative R


    2017; 45(9): 1193-1200

    Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.

    Guarino M, Morisco F, Valvano MR, Ippolito AM, Librandi M, Andriulli N, Greco M, Amoruso A, Iacobellis A, Niro G, Caporaso N, Andriulli A


    2017; 49(9): 1022-1028

    HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

    Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fon


    2017; ():

    A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study.

    Barone M, Iannone A, Shahini E, Ippolito AM, Brancaccio G, Morisco F, Milella M, Messina V, Smedile A, Conti F, Gatti P, Santantonio T, Tundo P, Lauletta G, Napoli N, Masetti C, Termite AP, Francavilla R, Di Leo A, Pesce F, Andriulli A


    2016; ():

    Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.

    Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, Siena D, Caruso M, Ippolito A, Mannuccio PM, Andriulli A


    2016; ():

    Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.

    Violi F, Corazza RG, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S, PRO-LIVER Collaborators


    2016; ():

    Metabolomic profile in pancreatic cancer patients: a consensusbased approach to identify highly discriminating metabolites.

    Di Gangi IM, Mazza T, Fontana A, Copetti M, Fusilli C, Ippolito A, Mattivi F, Latiano A, Andriulli A, Vrhovsek U, Pazienza V


    2015; 9(1): 52-7

    HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.

    Andriulli A, Morisco F, Ippolito AM, Di Marco V, Valvano MR, Angelico M, Fattovich G, Granata R, Smedile A, Milella M, Felder M, Gaeta GB, Gatti P, Fasano M, Mazzella G, Santantonio T


    2014; 34(9): 1369-77

    Variation in genes encoding for interferon ?-3 and ?-4 in the prediction of HCV-1 treatment-induced viral clearance.

    Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A


    2014; 46(9): 818-25

    An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.

    Andriulli A, Nardi A, Di Marco V, Ippolito AM, Gavrila C, Aghemo A, Di Paolo D, Squadrito G, Grassi E, Calvaruso V, Valvano MR, Brancaccio G, Craxi A, Angelico M, Collaborators, Collaborators


    2014; 60: S312

    Hcv genotype 1a and 1b: similarities and differences in clinical features, therapeutic outcome and predictors of response

    F. Morisco, V. Di Marco, R. Granata, S. Camera, Ippolito A, M. Margaglione, G. Fattovich, A. Smedile, E. Clery, C. Ferraiuoli, M. Guarino, L. Donnarumma, Valvano MR, M. Milella, M.M. Felder, G.B. Gaeta, P. Gatti, P. Tundo, M. Barone, R. Cozzolongo, M. Ang

    2014; 60: S456

    A model to estimate a priori the probability of sustained virological response to peg-interferon and ribavirin for patients with hcv-1 infection

    Andriulli A, Angelico M, Nardi, Ippolito A.M., C. Gravila, V. Calvaruso, Valvano M.R., V. Di Marco, A. Craxì.

    2014; 46S: S123

    Clinical Features, Therapeutic Outcome And Predictor Of Response In HCV Genotype 1A And 1B: Similarities And Differences

    Morisco F., Di Marco V., Caporaso N., Granata R., Camera S., Ippolito A., Margaglione M., Fattovich G., Smedile A., Clery E., Ferraiuoli C., Cossiga V., Guarino M., Donnarumma L., Valvano M.R., Milella M., Felder M.M., Gaeta G.B., Gatti P., Tundo P., Baro

    2014; 46S: S12

    A model to predict success following peg-interferon and ribavirin therapy for patients with HCV-1 infection

    Ippolito A.M., Andriulli A., Angelico M., Nardi A., Di Marco V., Smedile A., Calvaruso V., Valvano M.R., Milella M., Morisco F., Fattovich G., Felder M., Brancaccio G., Fasano M., Gatti P., Andriulli N., Tundo P., Barone M., Cozzolongo R., D'Andrea G., Ma

    2014; ():

    Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.

    Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A


    XVI Congresso Nazionale SIGU 2013; : P273

    Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

    Palmieri O., D'andrea G., De Girolamo G., Di Marco V., Margaglione M., Ippolito A.M., Fattovich G., Smedile A., Valvano M.R., Calvaruso V., Gioffreda D., Milella M., Morisco F., Felder M., Brancaccio G., Fasano M., Gatti P., Tundo P., Barone M., Cozzolong

    AISD - 36° Congresso Nazionale 2013; : 55

    Safety and efficacy of effentora to treat acute moderate oncological pain in a cirrhotic patient without previous strong opioid therapy

    Latina P., Andriulli A., Niro A., Conoscitore P., Ippolito A., Nardella M., Iacobellis A.

    Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P321

    The TT/-G frameshift variant of the novel IFNL4 gene not improves HCV1 clearance prediction

    Palmieri O., D'andrea G. , Ippolito A.M., De Girolamo G. , Margaglione M., Latiano A., Valvano M.R., Gioffreda D., Fasano M., Milella M., Morisco F., Montalto G., Gatti P., Tundo P., Barone M., Cozzolongo R., Santantonio T., Andriulli A.

    2013; 60(1): 16-21

    Identification of Naïve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Marco VD, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate M


    2013; 20(7): 502-9

    Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

    Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


    2012; ():

    Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Iacobellis A, Valvano MR, Spirito F, Ippolito A, Bossa F, Terracciano F, Fontana R, Niro G


    2012; :

    Epidemiology and diagnosis of hepatitis D virus

    Niro GA, Fontana R, Ippolito AM, Andriulli A

    2012; 56: s427

    A substantial proportion of naive HCV-1 infected patients with chronic infection may benefit from current standard therapy with PEG-interferon and ribavirin

    Andriulli A, Valvano MR, Spirito F, Ippolito A, Iacobellis A, Bossa F, Terracciano F, Niro G

    2012; 56: S262

    Hemorrhagic complications following invasive procedures in cirrhotic patients with normal or abnormal coagulopathy. A prospective study

    Napolitano G, Valvano MR, Caruso N, Merla A, Lauriola W, Ippolito A, Siena D, Niro G, Florio F, Andriulli A

    2011; 54(4): 605A

    Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

    Niro GA et al.

    2011; 18(7): e206-11

    Unawareness of HBV infection among inpatients in a Southern Italian hospital.

    Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A